In the latest session, Protara Therapeutics Inc (NASDAQ: TARA) closed at $3.63 down -9.70% from its previous closing price of $4.02. In other words, the price has decreased by -$0.3900 from its previous closing price. On the day, 8567892 shares were traded. TARA stock price reached its highest trading level at $5.2400 during the session, while it also had its lowest trading level at $3.5600.
Ratios:
For a deeper understanding of Protara Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.17 and its Current Ratio is at 11.17. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On June 04, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $40.
On February 17, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $43.Oppenheimer initiated its Outperform rating on February 17, 2021, with a $43 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 41.39M and an Enterprise Value of -18.72M.
Stock Price History:
Over the past 52 weeks, TARA has reached a high of $4.95, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is 3.6497, while the 200-Day Moving Average is calculated to be 2.3677.
Shares Statistics:
For the past three months, TARA has traded an average of 78.05K shares per day and 913.81k over the past ten days. A total of 11.36M shares are outstanding, with a floating share count of 9.15M. Insiders hold about 20.00% of the company’s shares, while institutions hold 36.64% stake in the company. Shares short for TARA as of Mar 15, 2024 were 61.44k with a Short Ratio of 0.79, compared to 58.98k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.54% and a Short% of Float of 0.82%.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.91 for the current quarter, with a high estimate of -$0.64 and a low estimate of -$1.07, while EPS last year was -$0.8. The consensus estimate for the next quarter is -$0.89, with high estimates of -$0.49 and low estimates of -$1.12.
Analysts are recommending an EPS of between -$2.07 and -$5.35 for the fiscal current year, implying an average EPS of -$3.95. EPS for the following year is -$4.23, with 4 analysts recommending between -$2.1 and -$5.95.
